Search

Author/Creator Ha, Su-Jeong

1. A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations. Issue 49 (4th December 2020)

Authors:
Song, Si-Yeon; Ha, Su-Jeong; Park, Ji-Hye; Park, So-Jung; Shin, Seong Hoon; Oak, Chulho; Choi, Jun-Yong; Yoon, Seong Woo; Kim, Jung-A; Yoon, Seong Hoon; Son, Ji Woong; Kim, Seung Joon; Yoo, Hwa-Seung
Journal:
Medicine
Issue:
Volume 99:Issue 49(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search